| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
180 Life Sciences Corp (NASDAQ: ATNF)
ATNF Technical Analysis
4
| As on 9th Jun 2023 ATNF STOCK Price closed @ 1.21 and we RECOMMEND Sell for LONG-TERM with Stoploss of 1.72 & Strong Sell for SHORT-TERM with Stoploss of 3.30 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ATNFSTOCK Price
| Open | 1.22 | Change | Price | % |
| High | 1.23 | 1 Day | -0.01 | -0.82 |
| Low | 1.16 | 1 Week | 0.03 | 2.54 |
| Close | 1.21 | 1 Month | 0.11 | 10.00 |
| Volume | 131339 | 1 Year | -3.16 | -72.31 |
| 52 Week High 5.81 | 52 Week Low 0.26 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ATNF Daily Charts |
ATNF Intraday Charts |
Whats New @ Bazaartrend |
ATNF Free Analysis |
|
|
ATNF Important Levels Intraday
| RESISTANCE | 1.34 |
| RESISTANCE | 1.30 |
| RESISTANCE | 1.27 |
| RESISTANCE | 1.25 |
| SUPPORT | 1.17 |
| SUPPORT | 1.15 |
| SUPPORT | 1.12 |
| SUPPORT | 1.08 |
ATNF Forecast May 2024
| 4th UP Forecast | 4.66 |
| 3rd UP Forecast | 3.55 |
| 2nd UP Forecast | 2.87 |
| 1st UP Forecast | 2.19 |
| 1st DOWN Forecast | 0.23 |
| 2nd DOWN Forecast | -0.45 |
| 3rd DOWN Forecast | -1.13 |
| 4th DOWN Forecast | -2.24 |
ATNF Weekly Forecast
| 4th UP Forecast | 2.39 |
| 3rd UP Forecast | 2.01 |
| 2nd UP Forecast | 1.78 |
| 1st UP Forecast | 1.54 |
| 1st DOWN Forecast | 0.88 |
| 2nd DOWN Forecast | 0.64 |
| 3rd DOWN Forecast | 0.41 |
| 4th DOWN Forecast | 0.03 |
ATNF Forecast2024
| 4th UP Forecast | 16.14 |
| 3rd UP Forecast | 11.35 |
| 2nd UP Forecast | 8.39 |
| 1st UP Forecast | 5.43 |
| 1st DOWN Forecast | -3.01 |
| 2nd DOWN Forecast | -5.97 |
| 3rd DOWN Forecast | -8.93 |
| 4th DOWN Forecast | -13.72 |
180 Life Sciences Corp ( NASDAQ USA Symbol : ATNF )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ATNF Business Profile
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, inflammation, inflammatory diseases, and fibrosis. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and anti-tumour necrosis factor (Anti-TNF) platform, which focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California. Address: 3000 El Camino Real, Palo Alto, CA, United States, 94306
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service